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Available online xxxxPurpose: Insomnia has adverse effects on people with epilepsy. We aimed to test a novel cognitive behavioral
therapy for insomnia (CBT-I) app-based intervention on insomnia symptoms and social psychological factors
in people with epilepsy and to examine the possible mechanisms among the factors.
Methods: Participants were recruited from neurology clinics in Iran and comprised individuals diagnosed with
epilepsy and having moderate to severe insomnia. A two-arm randomized controlled trial design was used,
consisting of a treatment group (CBT-I; n = 160) and control group (patient education; n = 160). Primary out-
comes were self-reported sleep quality, insomnia severity, and sleep hygiene behavior and objective sleep char-
acteristics measured by actigraphy. Secondary outcomes were attitude, perceived behavioral control, intention,
action planning, coping planning, behavioral automaticity, self-monitoring, anxiety, depression, and quality of
life (QoL). All outcomes were measured at baseline, and at one, three, and six months postintervention, except
objective sleep, which was assessed at baseline, and one and six months postintervention. Data were analyzed
using linear mixed models.
Results: Current findings showed that sleep quality, insomnia severity, sleep hygiene behavior, and sleep onset
latency were significantly improved in the CBT-I group compared with the patient education group at all mea-
surement points. Also, the CBT-I group had significantly improved anxiety, depression, and QoL compared
with thepatient education group.Mediation analyses showed that attitude, intention, coping planning, self-mon-
itoring, and behavioral automaticity significantly mediated the effect of the intervention on sleep outcomes.
Conclusion: Results support the use of the CBT-I app to improve sleep outcomes among people with epilepsy.





Epilepsy is one of the most common neurological diseases globally,
affecting around 50million people worldwide [1]. Individuals with epi-
lepsy often have other physical andmental health conditions [2]. For ex-
ample, higher incidences of anxiety, depression, and sleep–wake
disorders are commonly observed in people with epilepsy [2], all of
which have been shown to be associated with insomnia [2].alth Research Center, Research
, Qazvin University of Medical
.
our).Insomnia is characterized by difficulty initiating or maintaining
sleep or early-morning awakening with an inability to return to sleep
despite good opportunities for sleep [3]. Insomnia can have significant
negative consequences on a person including disruptions to psychoso-
cial functioning (e.g., depression, daytime dysfunction, reduced quality
of life (QoL)) and occupational functioning (e.g., job absence, reduced
ability to do tasks, lowered job satisfaction, poor decision-making), as
well as an increased burden on society (e.g., increased health costs, re-
duced job productivity) [2–4]. Several treatment options have been
used tomanage insomnia in peoplewith epilepsy; however, treatments
are often dependent on the seizure type, the person's age, preexisting
medical conditions, and potential side-effect profile [5]. Moreover, in
Iran, the usual practice for improving sleep hygiene for those who
have sleep difficulties is providing education through the provision of
